Sci Show: The approval of ketamine for treatment-resistant depression was a major advance in psychiatry. Researchers discovered proteins called 4E-BPs, involved in memory, is key to unlocking its antidepressant effect. When 4E-BPs are absent in the brain, ketamine cannot produce its antidepressant effect.

Sunday, December 20, 2020

The approval of ketamine for treatment-resistant depression was a major advance in psychiatry. Researchers discovered proteins called 4E-BPs, involved in memory, is key to unlocking its antidepressant effect. When 4E-BPs are absent in the brain, ketamine cannot produce its antidepressant effect.

https://ift.tt/3nC8Aol via /r/science https://ift.tt/3rbkFTA

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)